Resurgent Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Buy
5,580
+835
+18% +$853K 1.86% 7
2026
Q1
$4.36M Buy
4,745
+3,780
+392% +$3.83M 1.58% 11
2025
Q4
$1.04M Buy
965
+3
+0.3% +$2.87K 0.52% 50
2025
Q3
$734K Buy
962
+140
+17% +$104K 0.36% 74
2025
Q2
$641K Buy
822
+98
+14% +$76.2K 0.35% 78
2025
Q1
$598K Buy
724
+26
+4% +$21.6K 0.36% 78
2024
Q4
$539K Buy
698
+96
+16% +$79.5K 0.32% 93
2024
Q3
$533K Buy
602
+8
+1% +$7.19K 0.31% 91
2024
Q2
$538K Sell
594
-66
-10% -$52.8K 0.33% 90
2024
Q1
$513K Buy
660
+69
+12% +$49.1K 0.27% 104
2023
Q4
$345K Buy
591
+5
+0.9% +$2.92K 0.21% 121
2023
Q3
$315K Buy
586
+21
+4% +$10.8K 0.21% 106
2023
Q2
$265K Buy
565
+40
+8% +$16.8K 0.18% 117
2023
Q1
$180K Sell
525
-173
-25% -$58.3K 0.12% 159
2022
Q4
$255K Sell
698
-40
-5% -$14.2K 0.13% 161
2022
Q3
$239K Buy
+738
New +$234K 0.16% 160

Other funds holding LLY

Resurgent Financial Advisors's LLY Position: Q2 2026 in Review

Resurgent Financial Advisors increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $853K and bringing the position to 5,580 shares worth $6.69M. The position accounts for 1.86% of the portfolio, ranked #7.

Resurgent Financial Advisors first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Resurgent Financial Advisors held 5,580 shares of Eli Lilly worth $6.69M as of Q2 2026.
  • Resurgent Financial Advisors bought 835 Eli Lilly shares in Q2 2026, an estimated $853K.
  • Eli Lilly made up 1.86% of Resurgent Financial Advisors's portfolio in Q2 2026, its #7 holding.
  • Resurgent Financial Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Resurgent Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.